communityacquir
pneumonia
cap
import
respiratori
diseas
fifth
lead
caus
mortal
europ
develop
molecular
diagnost
test
highlight
contribut
respiratori
virus
aetiolog
cap
suggest
incid
viral
pneumonia
may
previous
underestim
perform
systemat
review
metaanalysi
describ
overal
identif
respiratori
virus
adult
patient
cap
europ
follow
prisma
guidelin
prospero
search
embas
medlin
cinahl
wholi
cochran
librari
grey
literatur
sourc
relev
studi
screen
protocol
elig
criteria
two
research
perform
data
extract
risk
bia
assess
independ
use
pilot
form
result
synthesis
narr
random
effect
metaanalys
perform
calcul
pool
estim
effect
heterogen
quantifi
use
twentyeight
studi
met
inclus
criteria
includ
primari
metaanalysi
pool
proport
patient
identifi
respiratori
virus
ci
rise
studi
polymeras
chain
reaction
pcr
diagnost
perform
influenza
viru
frequent
detect
viru
adult
cap
respiratori
virus
make
substanti
contribut
aetiolog
cap
adult
patient
europ
one
respiratori
virus
detect
one
quarter
case
communityacquir
pneumonia
cap
princip
caus
excess
hospitalis
mortal
worldwid
histor
overrid
clinic
approach
manag
cap
focu
bacteri
aetiolog
streptococcu
pneumonia
domin
pathogen
recent
coupl
increas
avail
polymeras
chain
reaction
pcr
test
identif
viral
pathogen
aetiolog
cap
increas
contemporari
studi
identifi
virus
may
implic
cap
turn
heighten
possibl
empir
antibiot
treatment
cap
absenc
adequ
test
viral
pathogen
may
contribut
inappropri
antibiot
usag
given
consider
variat
across
individu
studi
estim
contribut
respiratori
virus
cap
aetiolog
reliabl
summari
relev
data
necessari
inform
futur
research
polici
initi
particularli
new
respiratori
viru
vaccin
antivir
drug
anticip
short
medium
term
two
recent
systemat
review
studi
investig
proport
viral
pathogen
patient
cap
focuss
studi
use
polymeras
chain
reaction
pcr
base
assay
detect
viral
pathogen
pool
result
studi
conduct
across
world
report
addit
systemat
review
studi
conduct
within
world
health
organ
european
region
offer
addit
granular
accord
set
time
studi
viral
diagnost
techniqu
studi
qualiti
studi
protocol
regist
nation
institut
health
research
intern
prospect
regist
systemat
review
prospero
avail
http
wwwcrd
yorkacukprosperodisplayrecordasp
conduct
accord
prefer
report
item
systemat
review
metaanalys
prisma
guidelin
identifi
studi
investig
aetiolog
cap
adult
europ
defin
countri
cover
region
offic
europ
http
wwweurowhointencountri
report
quantit
data
identif
respiratori
virus
search
origin
articl
describ
longitudin
studi
case
seri
english
investig
adult
age
year
diagnos
cap
studi
design
exclud
includ
studi
perform
either
pcr
nonpcr
detect
techniqu
exclud
studi
paediatr
popul
patient
resid
nurs
home
residenti
care
home
rehabilit
facil
studi
adult
diagnos
cap
base
clinic
sign
without
radiolog
confirm
studi
focus
cap
adult
sever
immunosuppress
diseas
andor
drug
treatment
also
exclud
follow
electron
databas
systemat
search
embas
medlin
cinahl
wholi
web
scienc
januari
april
comprehens
search
strategi
develop
embas
supplementari
appendix
subsequ
adjust
requir
suit
databas
refer
list
elig
articl
manual
search
identifi
elig
studi
identifi
articl
import
endnot
softwar
thomson
reuter
toronto
ca
usa
duplic
remov
two
review
author
ya
jsnvt
independ
screen
retain
articl
protocol
elig
criteria
three
stage
titl
abstract
full
text
disagr
resolv
discuss
ya
jsnvt
third
author
wsl
adjud
outstand
discrep
data
extract
elig
studi
also
perform
independ
ya
jsnvt
use
prepilot
data
extract
form
use
microsoft
offic
excel
microsoft
corpor
richmond
va
usa
includ
studi
inform
extract
author
year
public
countri
healthcar
set
number
evalu
patient
viral
diagnost
techniqu
employ
sampl
collect
viru
detect
number
respiratori
viru
pathogen
test
number
proport
respiratori
virus
detect
ya
jsnvt
independ
assess
qualiti
includ
studi
use
criteria
adapt
newcastl
ottawa
scale
observ
studi
focus
three
key
domain
repres
patient
popul
ascertain
cap
diagnosi
ascertain
viru
aetiolog
award
zero
one
star
domain
repres
one
star
award
studi
sampl
gener
commun
oppos
specialis
patient
subgroup
ascertain
cap
diagnosi
award
one
star
independ
radiograph
confirm
diagnosi
viru
aetiolog
one
star
use
gold
standard
pcr
diagnost
techniqu
proport
respiratori
virus
identifi
evalu
cap
patient
pool
use
gener
invers
varianc
approach
base
random
effect
model
dersimonianlaird
weight
method
stabilis
varianc
use
freemantukey
doubl
arcsin
transform
studi
proport
close
appropri
estim
exact
binomi
confid
interv
comput
outcom
primari
outcom
overal
contribut
respiratori
virus
aetiolog
cap
calcul
total
number
patient
respiratori
virus
identifi
numer
proport
total
number
evalu
patient
denomin
report
secondari
outcom
contribut
individu
virus
calcul
total
number
patient
individu
respiratori
virus
identifi
proport
evalu
patient
specif
pathogen
heterogen
studi
quantifi
use
statist
investig
potenti
sourc
heterogen
perform
subgroup
analys
studi
set
inpati
vs
outpati
studi
qualiti
viral
diagnost
method
use
pcr
diagnost
techniqu
vs
nonpcr
method
mix
infect
bacteri
viral
infect
analys
conduct
use
metaprop
command
within
stata
stata
corp
colleg
station
texa
usa
identifi
total
articl
databas
search
reduc
remov
duplic
eleven
addit
paper
identifi
via
citat
track
screen
articl
remain
within
protocol
elig
criteria
fig
one
includ
articl
present
two
separ
studi
data
extract
present
separ
thu
studi
articl
includ
systemat
review
primari
metaanalysi
examin
fulltext
articl
seven
studi
present
suffici
quantit
data
inclus
primari
metaanalysi
fig
studi
includ
systemat
review
prospect
retrospect
longitudin
studi
caseseri
patient
popul
size
rang
total
earliest
public
recent
articl
publish
octob
studi
differ
european
countri
includ
spain
frequent
repres
studi
nineteen
studi
carri
among
inpati
popul
n
patient
three
outpatientcommun
popul
n
patient
six
mix
popul
n
patient
detail
characterist
includ
studi
summaris
tabl
sixteen
studi
use
pcr
techniqu
detect
respiratori
virus
alon
combin
diagnost
method
studi
obtain
upper
respiratori
sampl
lower
respiratori
six
studi
public
respiratori
tract
sampl
combin
assess
pair
serolog
four
studi
serolog
alon
perform
studi
popul
repres
diagnost
accuraci
cap
ascertain
viru
aetiolog
assess
maximum
three
star
per
studi
eleven
studi
assess
low
risk
bia
three
star
one
star
per
domain
studi
moder
risk
bia
star
three
high
risk
bia
one
zero
star
six
studi
report
difficulti
obtain
adequ
sampl
microbiolog
test
withinstudi
variat
viral
diagnost
method
across
differ
studi
year
report
ten
studi
percentag
respiratori
virus
detect
cap
patient
rang
spanish
studi
compris
inpati
outpati
studi
hospitalis
patient
israel
metaanalysi
pool
proport
respiratori
virus
detect
cap
patient
ci
fig
signific
trend
identif
respiratori
viru
pathogen
lower
studi
n
ci
studi
mix
popul
n
fig
popul
reveal
result
statist
significantli
differ
test
subgroup
differ
p
studi
mix
popul
reli
exclus
nonpcr
diagnost
method
lower
qualiti
compar
studi
pool
proport
respiratori
viral
pathogen
identifi
studi
use
pcr
without
addit
test
method
ci
compar
ci
nine
studi
use
nonpcr
method
signific
differ
two
group
p
fig
lower
risk
bia
studi
no
score
star
pool
proport
total
respiratori
viral
pathogen
ci
compar
ci
higher
risk
bia
studi
no
score
star
explain
observ
overal
heterogen
studi
p
fig
pool
proport
mix
respiratori
virus
bacteri
coinfect
detect
cap
patient
ci
fig
data
seven
common
respiratori
virus
identifi
present
tabl
influenza
virus
frequent
detect
follow
rhinovirus
coronavirus
togeth
account
major
respiratori
virus
detect
tabl
review
updat
evid
microbiolog
identif
respiratori
viral
pathogen
adult
patient
radiograph
confirm
cap
europ
overal
data
suggest
respiratori
virus
detect
least
radiolog
confirm
cap
case
mostli
hospitalis
case
howev
significantli
higher
proport
respiratori
virus
evid
studi
conduct
studi
includ
viral
pcr
techniqu
studi
assess
lower
risk
bia
suggest
true
proport
cap
associ
respiratori
virus
least
one
quarter
find
accord
recent
major
studi
review
conduct
asia
north
america
cdc
epic
studi
virus
detect
adult
patient
cap
qu
et
al
detect
virus
asian
patient
cap
review
suggest
europ
part
world
rel
larg
burden
cap
diseas
may
attribut
viral
infect
howev
clinicopatholog
signific
viru
detect
patient
cap
remain
uncertain
clear
limit
approach
includ
studi
proof
offer
viru
virus
identifi
patholog
signific
case
also
heterogen
studi
term
respiratori
site
sampl
andor
use
serolog
virus
recov
upper
respiratori
tract
urt
site
might
less
patholog
signific
recov
lower
respiratori
tract
lrt
site
nevertheless
absenc
concomit
sampl
urt
lrt
possibl
disregard
virus
identifi
urt
site
may
replic
lrt
also
sampl
whilst
respiratori
virus
undoubtedli
implic
aetiolog
substanti
proport
case
detect
asymptomat
ill
associ
viru
shed
well
recognis
especi
children
experi
longer
period
shed
adult
addit
modern
pcr
diagnost
techniqu
compar
sensit
method
detect
bacteria
capabl
detect
small
quantiti
nucleic
acid
may
case
repres
cultur
viru
therefor
patient
viralonli
pathogen
identifi
may
also
microbiolog
unrecognis
bacteri
infect
detect
viral
pathogen
may
repres
previou
resolv
viru
infect
recent
studi
gadsbi
et
al
employ
pcr
techniqu
identifi
bacteria
well
virus
lower
respiratori
tract
sampl
virus
detect
adult
admit
hospit
cap
cobacteri
pathogen
detect
contrast
note
case
bacteri
copathogen
might
reflect
use
pcr
test
bacteria
gadsbi
colleagu
wherea
studi
includ
use
standard
approach
identif
bacteria
detect
respiratori
virus
healthi
asymptomat
individu
extens
describ
symptomat
patient
nevertheless
jartti
colleagu
summaris
data
studi
note
maximum
baselin
preval
respiratori
virus
asymptomat
subject
follow
rhinovirus
adenovirus
influenza
rsv
coronavirus
eneterovirus
human
bocaviru
parainfluenza
hmpv
jansen
colleagu
observ
rhinoviru
extrem
common
asymptomat
children
virus
identifi
notabl
rsv
adenovirus
hmpv
much
like
clinic
relev
may
differ
adult
lack
direct
comparison
asymptomat
control
group
includ
studi
access
data
host
respons
virus
individu
subject
howev
separ
studi
asymptomat
patient
offer
import
contextu
find
inclus
asymptomat
compar
group
would
like
add
granular
futur
studi
sinc
previou
work
identifi
high
heterogen
extant
literatur
part
world
expect
decid
priori
high
heterogen
would
preclud
metaanalysi
unabl
identifi
singl
clear
reason
observ
high
heterogen
attribut
multipl
factor
includ
studi
qualiti
fig
variabl
set
patient
popul
sampl
site
diagnost
method
fig
diseas
sever
coinfect
pathogen
sinc
rhinoviru
respiratori
syncyti
viru
rsv
rsv
infect
predilect
asthmat
patient
underli
comorbid
may
also
influenc
find
influenza
virus
rhinovirus
coronavirus
account
major
viru
detect
proport
similar
estim
report
previous
burk
et
al
wu
et
al
howev
rsv
identifi
adult
cap
may
relev
potenti
role
futur
rsv
vaccin
target
elderli
find
highlight
import
respiratori
virus
aetiolog
adult
cap
potenti
relev
find
toward
improv
clinic
outcom
reduc
inappropri
antibiot
use
influenza
appear
signific
viru
pathogen
follow
rhinovirus
coronavirus
notwithstand
differ
includ
studi
test
separ
respiratori
virus
tabl
includ
studi
test
virus
overal
proport
viru
detect
may
well
consider
higher
although
discuss
detect
necessarili
clinic
relev
cap
potenti
sourc
bia
affect
estim
individu
virus
tabl
analys
organismspecif
base
avail
data
organ
viral
diagnost
evalu
cap
facilit
greater
precis
assess
ill
sever
tailor
therapi
particular
rapid
use
neuraminidas
inhibitor
case
influenza
judici
use
antibiot
sinc
realist
nearterm
prospect
novel
antivir
treatment
sever
respiratori
viru
infect
rsv
vaccin
need
establish
baselin
data
incid
viral
cap
develop
wider
cultur
test
respiratori
viru
pathogen
without
difficult
assess
impact
advanc
therapi
includ
articl
report
english
analysi
includ
countryspecif
data
report
languag
may
reveal
region
variat
contribut
respiratori
virus
microbiolog
cap
although
effect
age
consid
import
sourc
heterogen
subanalysi
age
could
perform
due
lack
detail
report
studi
result
age
group
may
influenc
result
similarli
subgroup
analys
could
perform
accord
patient
ill
sever
patient
comorbid
type
respiratori
sampl
presenc
specif
bacteri
copathogen
due
lack
data
public
bia
appli
studi
report
posit
find
like
publish
report
neg
find
import
consider
metaanalys
evalu
treatment
effect
howev
context
studi
examin
proport
cap
patient
virus
detect
wellconduct
neg
studi
surpris
posit
studi
would
expect
publish
first
studi
examin
use
standard
public
bia
test
proport
metaanalys
one
found
funnel
plot
statist
test
potenti
yield
mislead
result
especi
proport
within
studi
either
high
low
research
describ
altern
method
use
explor
potenti
public
bia
sampl
size
use
instead
standard
error
studi
howev
reliabl
accuraci
method
yet
fulli
explor
independ
valid
therefor
elect
analys
public
bia
systemat
review
suggest
europ
respiratori
virus
identifi
one
quarter
adult
present
cap
frequent
identifi
pathogen
influenza
virus
rhinovirus
coronavirus
account
one
half
identifi
viral
pathogen
studi
determin
import
identifi
viral
pathogen
relat
treatment
antibiot
antivir
warrant
author
design
contribut
systemat
review
ya
js
nvt
perform
studi
select
independ
ya
js
nvt
perform
pair
data
extract
data
synthesi
quantit
analys
ya
js
nvt
draft
articl
author
critic
review
articl
submiss
studi
undertaken
ya
master
public
health
intern
health
dissert
univers
nottingham
specif
grant
fund
agenc
public
commerci
notforprofit
sector
potenti
conflict
interest
jsnvt
report
research
grant
world
health
organ
f
hoffmanla
roch
glaxosmithklin
unconnect
submit
work
honoraria
novavax
prep
biopharm
also
nonfinanci
support
european
scientif
work
group
influenza
eswi
support
deliveri
plenari
lectur
scientif
confer
wsl
report
institut
receiv
unrestrict
investig
initi
research
fund
pfizer
pneumonia
cohort
studi
author
declar
conflict
